We are live on ! Find out more
MYOK

MyoKardia, Inc. Common Stock
MYOK

Delisted

MYOK was delisted on the 16th of November, 2020.

73 hedge funds and large institutions have $196M invested in MyoKardia, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

69% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 16

3% more funds holding

Funds holding: 7173 (+2)

0% more capital invested

Capital invested by funds: $195M → $196M (+$503K)

Holders
73
Holders Change
+2
Holders Change %
+2.82%
% of All Funds
1.82%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
17
Increased
27
Reduced
16
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Bessemer Group
51
Bessemer Group
New Jersey
$135K +$18.5K +1,447 +16%
Barclays
52
Barclays
United Kingdom
$102K -$4.8K -375 -5%
NFA
53
Nationwide Fund Advisors
Ohio
$94K
AIG
54
American International Group
New York
$92K +$6.71K +524 +8%
Legal & General Group
55
Legal & General Group
United Kingdom
$52K
TIM
56
Tortoise Investment Management
New York
$45K
Bank of America
57
Bank of America
North Carolina
$31K +$2.83K +221 +10%
Creative Planning
58
Creative Planning
Kansas
$26K
Canada Life
59
Canada Life
Manitoba, Canada
$22K
FPFS
60
First Personal Financial Services
North Carolina
$12K
AIP
61
Ameritas Investment Partners
Nebraska
$12K +$11.2K +877 New
AIM
62
Acrospire Investment Management
Illinois
$12K +$11.6K +905 New
IA
63
IFP Advisors
Florida
$7K
Royal Bank of Canada
64
Royal Bank of Canada
Ontario, Canada
$7K +$2.11K +165 +49%
UBS Group
65
UBS Group
Switzerland
$5K -$20.5K -1,597 -80%
MAM
66
Meeder Asset Management
Ohio
$5K +$4.54K +354 New
PCM
67
Prelude Capital Management
New York
$3K +$2.56K +200 New
IUHSA
68
Itau Unibanco Holding S.A.
Brazil
$3K +$2.77K +216 New
PHK
69
Point72 Hong Kong
Hong Kong
$2K +$2.02K +158 New
BNP Paribas Financial Markets
70
BNP Paribas Financial Markets
France
$1.05K -$1.74K -136 -63%
AG
71
Advisor Group
Arizona
$1K +$641 +50 New
TRCT
72
Tower Research Capital (TRC)
New York
$1K +$1.28K +100 New
Marshall Wace
73
Marshall Wace
United Kingdom
-$1.57M -121,304 Closed
SFM
74
Sphera Funds Management
Israel
-$1.08M -83,240 Closed
Norges Bank
75
Norges Bank
Norway
-$869K -67,142 Closed

MYOK Hedge Fund Activity: Q1 2017 in Review

73 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q1 2017, worth a combined $196M — up 0.26% from $195M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new MYOK positions and 10 closed out — a net gain of 7 holders — while 27 added to existing stakes and 16 trimmed.

The largest buyer was BlackRock, adding an estimated $8.29M. The largest seller was Fidelity Investments, cutting an estimated $7.97M.

  • 73 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q1 2017, up from 71 in Q4 2016.
  • Funds reported $196M of MyoKardia, Inc. Common Stock stock for Q1 2017, up 0.26% quarter-over-quarter.
  • 17 funds opened new MyoKardia, Inc. Common Stock positions in Q1 2017 and 10 closed out, a net change of +7 holders.
  • The largest MyoKardia, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $8.29M added.
  • The largest MyoKardia, Inc. Common Stock seller in Q1 2017 was Fidelity Investments, an estimated $7.97M sold.

Based on aggregated 13F filings for Q1 2017.